Mylan inks deal for generic biologics

Biocon, India's biggest biotechnology company, signed an agreement with Mylan to develop, make and market generic biologic drugs. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.